tiprankstipranks
Advertisement
Advertisement

INM Stock Latest News

InMed Reports Positive Preclinical Data for Alzheimer’s Candidate
Company AnnouncementsInMed Reports Positive Preclinical Data for Alzheimer’s Candidate
4d ago
8K
INM
InMed Pharmaceuticals announces preclinical data on effects of INM-901
PremiumThe Fly
InMed Pharmaceuticals announces preclinical data on effects of INM-901
4d ago
INM
InMed Pharmaceuticals files $50M mixed securities shelf
PremiumThe Fly
InMed Pharmaceuticals files $50M mixed securities shelf
6d ago
INM
InMed outlines 2026 development plans for lead programs
PremiumCompany Announcements
InMed outlines 2026 development plans for lead programs
18d ago
8K
INM
InMed Pharmaceuticals provides development outlook for 2026
PremiumThe Fly
InMed Pharmaceuticals provides development outlook for 2026
18d ago
INM
InMed Pharmaceuticals Exits BayMedica to Refocus on Pipeline
PremiumCompany AnnouncementsInMed Pharmaceuticals Exits BayMedica to Refocus on Pipeline
20d ago
8K
INM
InMed Highlights Q2 Results Amid Cash, Regulatory Pressures
Premium
Company Announcements
InMed Highlights Q2 Results Amid Cash, Regulatory Pressures
1M ago
8K
INM
InMed Shareholders Approve Directors and Equity Financing Flexibility
Premium
Company Announcements
InMed Shareholders Approve Directors and Equity Financing Flexibility
3M ago
8K
INM
InMed Faces Challenges from New U.S. Legislation
PremiumCompany Announcements
InMed Faces Challenges from New U.S. Legislation
3M ago
8K
INM
InMed Pharmaceuticals Completes Key Study for INM-901
PremiumCompany Announcements
InMed Pharmaceuticals Completes Key Study for INM-901
4M ago
8K
INM
InMed announces completion of pharmacokinetic studies for Alzheimer’s candidate
PremiumThe Fly
InMed announces completion of pharmacokinetic studies for Alzheimer’s candidate
4M ago
INM
InMed Completes Key Pharmacokinetic Studies for Alzheimer’s Candidate INM-901
PremiumCompany Announcements
InMed Completes Key Pharmacokinetic Studies for Alzheimer’s Candidate INM-901
4M ago
INM
InMed Pharmaceuticals Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsInMed Pharmaceuticals Reports Q3 2025 Financial Results
4M ago
INM
InMed Pharmaceuticals Advances Alzheimer’s Program Amidst Strong Fiscal Start
Premium
Company Announcements
InMed Pharmaceuticals Advances Alzheimer’s Program Amidst Strong Fiscal Start
5M ago
INM
InMed Pharmaceuticals Strengthens Board with Strategic Appointment
Premium
Company Announcements
InMed Pharmaceuticals Strengthens Board with Strategic Appointment
5M ago
INM
InMed Pharmaceuticals Strengthens Board with Appointment of Industry Veteran Neil Klompas
PremiumCompany Announcements
InMed Pharmaceuticals Strengthens Board with Appointment of Industry Veteran Neil Klompas
6M ago
INM
InMed Pharmaceuticals: Advancing Cannabinoid-Based Therapies
PremiumCompany Announcements
InMed Pharmaceuticals: Advancing Cannabinoid-Based Therapies
6M ago
INM
Trump links Tylenol use to autism, AutoZone reports downbeat Q4: Morning Buzz
PremiumThe Fly
Trump links Tylenol use to autism, AutoZone reports downbeat Q4: Morning Buzz
6M ago
AA
BA
InMed Pharmaceuticals Advances Alzheimer’s Program with Promising Results
PremiumCompany Announcements
InMed Pharmaceuticals Advances Alzheimer’s Program with Promising Results
6M ago
INM
InMed Pharmaceuticals reports FY25 EPS ($8.36) vs ($20.14) last year
PremiumThe FlyInMed Pharmaceuticals reports FY25 EPS ($8.36) vs ($20.14) last year
6M ago
INM
InMed Pharmaceuticals to Showcase Pipeline Progress at Global Investment Conference
Premium
Company Announcements
InMed Pharmaceuticals to Showcase Pipeline Progress at Global Investment Conference
7M ago
INM
InMed Pharmaceuticals to Present Promising INM-901 Data at AAIC 2025
Premium
Company Announcements
InMed Pharmaceuticals to Present Promising INM-901 Data at AAIC 2025
8M ago
INM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >